GP-Act III Acquisition Corp. (NASDAQ:GPAT) Short Interest Down 43.5% in September

GP-Act III Acquisition Corp. (NASDAQ:GPATGet Free Report) was the recipient of a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 1,300 shares, a drop of 43.5% from the August 31st total of 2,300 shares. Based on an average daily volume of 58,000 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 58,000 shares, the short-interest ratio is presently 0.0 days.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Citadel Advisors LLC purchased a new position in GP-Act III Acquisition in the fourth quarter valued at $103,000. Clear Street LLC increased its holdings in GP-Act III Acquisition by 8,429.8% in the second quarter. Clear Street LLC now owns 10,321 shares of the company’s stock valued at $109,000 after buying an additional 10,200 shares in the last quarter. Wellspring Financial Advisors LLC increased its holdings in GP-Act III Acquisition by 17.8% in the second quarter. Wellspring Financial Advisors LLC now owns 21,200 shares of the company’s stock valued at $224,000 after buying an additional 3,200 shares in the last quarter. Mizuho Securities USA LLC purchased a new position in GP-Act III Acquisition in the first quarter valued at $303,000. Finally, Shaolin Capital Management LLC purchased a new position in GP-Act III Acquisition in the second quarter valued at $1,055,000.

GP-Act III Acquisition Stock Down 0.1%

GPAT opened at $10.59 on Monday. GP-Act III Acquisition has a fifty-two week low of $10.05 and a fifty-two week high of $10.64. The company has a fifty day moving average of $10.58 and a two-hundred day moving average of $10.50.

Wall Street Analysts Forecast Growth

GPAT has been the subject of several recent research reports. Wall Street Zen raised shares of GP-Act III Acquisition to a “hold” rating in a report on Saturday, July 12th. Weiss Ratings reissued a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Saturday, September 27th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, GP-Act III Acquisition has an average rating of “Sell”.

Get Our Latest Report on GP-Act III Acquisition

About GP-Act III Acquisition

(Get Free Report)

GP-Act III Acquisition Corp. operates as a blank check company, which was created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on November 23, 2020 and is headquartered in New York, NY.

Featured Stories

Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.